Imperial College London
Alternate

DrSarahBlagden

Faculty of Medicine, Department of Surgery & Cancer

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

s.blagden

 
 
//

Location

 

Cyclotron buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Blagden:2015:10.1158/1078-0432.CCR-14-3188,
author = {Blagden, S and Omlin, A and Josephs, D and Stavraka, C and Zivi, A and Pinato, DJ},
doi = {10.1158/1078-0432.CCR-14-3188},
journal = {CLINICAL CANCER RESEARCH},
pages = {660--660},
title = {First-in-Human Study of CH5132799, an Oral Class I PI3K Inhibitor, Studying Toxicity, Pharmacokinetics, and Pharmacodynamics, in Patients with Metastatic Cancer (vol 20, pg 5908, 2014)},
url = {http://dx.doi.org/10.1158/1078-0432.CCR-14-3188},
volume = {21},
year = {2015}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Blagden,S
AU  - Omlin,A
AU  - Josephs,D
AU  - Stavraka,C
AU  - Zivi,A
AU  - Pinato,DJ
DO  - 10.1158/1078-0432.CCR-14-3188
EP  - 660
PY  - 2015///
SN  - 1078-0432
SP  - 660
TI  - First-in-Human Study of CH5132799, an Oral Class I PI3K Inhibitor, Studying Toxicity, Pharmacokinetics, and Pharmacodynamics, in Patients with Metastatic Cancer (vol 20, pg 5908, 2014)
T2  - CLINICAL CANCER RESEARCH
UR  - http://dx.doi.org/10.1158/1078-0432.CCR-14-3188
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000348908500023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 21
ER  -
Download